Shanghai Zhongxi Pharmaceutical Co. Ltd., or Shanghai Zhongxi Pharmaceutical Factory, is a pharmaceutical company manufacturing medicine. In particular anti-malaria medicines, including Chloroquine Phosphate Tablets, Primaquine Phosphate Tablets and Hydroxychloroquine sulfate Tablets.
The company is approved to be a cooperative partner of China CDC (Chinese Center of Disease Control and Prevention) and has become one of the main anti-malarial medicines suppliers for the Chinese Global Fund project.
As of February 2020, drugs produced by Shanghai Zhongxi Pharmaceutical, Shanghai Ziyuan Pharmaceutical, and Wuhan Wuyao Pharmaceutical are being used for clinical trials as candidates to treat coronavirus. Both Chloroquine and hydroxychloroquine, that act as Endosomal acidification fusion inhibitors, are part of at least 10 clinical trials.
Documentaries, videos and podcasts
- Cluster: BiotechnologyA cluster of topics related to biotechnology.
- Cluster: COVID-19A cluster of topics related to COVID-19. COVID-19 is the abbreviated name for coronavirus disease 2019, a respiratory disease caused by a novel coronavirus strain called SARS-CoV-2. COVID-19 was first detected in Wuhan City, China and the outbreak was declared a pandemic on March 11, 2020 by the WHO.